Senators Ask Why Medicare Is Reviewing Provenge
26 August 2010
By Ed Silverman, Pharmalot
The latest people to object to the recent decision by the
Centers for Medicare & Medicaid Services to open a National
Coverage Analysis of the Provenge prostate cancer vaccine happen to
be two US Senators. John Kerry and Arlen Specter, Democrats from
Massachusetts and Pennsylvania, respectively, wrote an Aug. 20
letter to the agency questioning the rationale for the review and
voicing suspicion the move will lead to restricted coverage.
Full article
DISCLAIMER
The links and content above are provided for your convenience to provide further information and do not constitute an endorsement by Bavarian Nordic. We have no control over the nature, content and availability of the sites that are being linked to and thus we assume no responsibility for the privacy practices on such websites.
